Cargando…

Trends in Industry Payments to Diabetologists and Endocrinologists in the United States During the COVID-19 Pandemic

Introduction Limited evidence suggests there were substantial amounts of payments from the healthcare industry to diabetologists and endocrinologists in the United States before the coronavirus disease 2019 (COVID-19) pandemic period. However, there is no study on how these industry payments changed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murayama, Anju, Kamamoto, Sae, Saito, Hiroaki, Tanimoto, Tetsuya, Ozaki, Akihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842187/ https://www.ncbi.nlm.nih.gov/pubmed/36654586 http://dx.doi.org/10.7759/cureus.32643

Ejemplares similares

The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States
por: Murayama, Anju, et al.
Publicado: (2022)

Research and Nonresearch Industry Payments for COVID-19 mRNA Vaccines in the United States
por: Murayama, Anju, et al.
Publicado: (2023)

Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic
por: Murayama, Anju, et al.
Publicado: (2022)

Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database between 2014 and 2020
por: Murayama, Anju, et al.
Publicado: (2022)

Evaluation of Financial Conflicts of Interest and Quality of Evidence Underlying the American Diabetes Association Clinical Practice Guidelines: The Standards of Medical Care in Diabetes, 2021
por: Shigeta, Haruki, et al.
Publicado: (2023)

Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States
por: Murayama, Anju, et al.
Publicado: (2023)

Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2023)

Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2023)

Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
por: Kusumi, Eiji, et al.
Publicado: (2022)

Pharmaceutical Payments to Japanese Board‐Certified Head and Neck Surgeons Between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2023)

Our Response to COVID-19 as Endocrinologists and Diabetologists
por: Kaiser, Ursula B, et al.
Publicado: (2020)

Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2022)

Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2022)

Can Clinicians Start Prescribing Inclisiran for Hypercholesterolemia Today? A Review of Clinical Studies for Internal Medicine Physicians and Endocrinologists
por: Jahangir, Abdullah, et al.
Publicado: (2021)

Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan
por: Murayama, Anju, et al.
Publicado: (2020)

Assessment of Financial Relationships Between Otorhinolaryngologists and Pharmaceutical Companies in Japan Between 2016 and 2019
por: Kamamoto, Sae, et al.
Publicado: (2023)

ODP193 Endocrinologists’ Experiences with Telehealth: Organizational and Logistical Issues with Implementation
por: Wong, Denise, et al.
Publicado: (2022)

Sociodemographic patterning of long-term diabetes mellitus control following Japan's 3.11 triple disaster: a retrospective cohort study
por: Leppold, Claire, et al.
Publicado: (2016)

ODP637 Clinical Appropriateness of Telehealth: A Qualitative Study of Endocrinologists’ Perspectives
por: Bolton, Rendelle, et al.
Publicado: (2022)

Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan
por: Sawano, Toyoaki, et al.
Publicado: (2019)

Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016
por: Shimada, Yuki, et al.
Publicado: (2019)

Consensus Statements from the Diabetologists & Endocrinologists Alliance for the Management of People with Hypertension and Type 2 Diabetes Mellitus
por: Tong, Peter Chun-Yip, et al.
Publicado: (2023)

Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan
por: Saito, Hiroaki, et al.
Publicado: (2019)

Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians
por: Murayama, Anju, et al.
Publicado: (2022)

Coronavirus disease 2019 experts appearing on Japanese television: their characteristics and financial conflicts of interest with pharmaceutical companies
por: Murayama, Anju, et al.
Publicado: (2021)

Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan
por: Hashimoto, Takanao, et al.
Publicado: (2022)

Pharmaceutical company payments to authors of the Japanese guidelines for the management of hypertension
por: Senoo, Yuki, et al.
Publicado: (2021)

Complications in Diabetes Mellitus: Social Determinants and Trends
por: Cuddapah, Gaurav Venkat, et al.
Publicado: (2022)

Is There Seasonality in Hypothyroidism? A Google Trends Pilot Study
por: Ilias, Ioannis, et al.
Publicado: (2019)

Mortality in Acromegalic Patients: Etiology, Trends, and Risk Factors
por: Alhawyan, Fatmah S
Publicado: (2021)

Obesity management: Attitudes and practice of Italian endocrinologists
por: Chianelli, Marco, et al.
Publicado: (2023)

Demographic Differences and Trends of Vitamin D Levels Among the Teenaged Girls in Balochistan
por: Rehman, Gulalai, et al.
Publicado: (2020)

COVID-19-Related Trends and Characteristics of Type 2 Diabetes Mellitus and Metabolic Syndrome
por: Franco, Brittany N, et al.
Publicado: (2022)

How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan
por: Ozaki, Akihiko, et al.
Publicado: (2022)

Dyslipidemia and Obesity in Ischemic Stroke
por: Gajurel, Bikram P, et al.
Publicado: (2023)

Risk Factors, Trends, and Preventive Measures for 30-Day Unplanned Diabetic Ketoacidosis Readmissions in the Pediatric Population
por: Vasireddy, Deepa, et al.
Publicado: (2021)

Profiles and Outcomes of Women with Gestational Diabetes Mellitus in the United States
por: Akinyemi, Oluwasegun A, et al.
Publicado: (2023)

Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis
por: Ozaki, Akihiko, et al.
Publicado: (2019)

Olanzapine-Induced Hyponatremia Presenting with Seizure Requiring Intensive Care Unit Admission
por: McNally, Michelle A, et al.
Publicado: (2020)

Endocrine and Metabolic Manifestations of COVID-19 Patients Admitted to an Intensive Care Unit
por: Arora, Saurabh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cn3vkdl6dpv553ejrelal9j3a4